SARS-CoV-2 impairs male fertility by targeting semen quality and testosterone level: A systematic review and meta-analysis
PLOS ONE · 09.09.2024 · 19 (9) · e0307396
DOI: 10.1371/journal.pone.0307396 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift PLOS ONE, online erschienen am 09.09.2024. Verfasst von Ashonibare V J und 3 weiteren Autor:innen. Beteiligte Einrichtung: Medical Faculty, Department of Cardiovascular Surgery and Research Group for Experimental Surgery, Cardiovascular Regenerative Medicine and Tissue En…. Hauptthemen laut MEDLINE: COVID-19, Fertility, SARS-CoV-2, Semen Analysis. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Since the discovery of COVID-19 in December 2019, the novel virus has spread globally causing significant medical and socio-economic burden. Although the pandemic has been curtailed, the virus and its attendant complication live on. A major global concern is its adverse impact on male fertility.
Aim
This study was aimed to give an up to date and robust data regarding the effect of COVID-19 on semen variables and male reproductive hormones. Materials and methods Literature search was performed according to the recommendations of PRISMA. Out of the 852 studies collected, only 40 were eligible for inclusion in assessing the effect SARS-CoV-2 exerts on semen quality and androgens. More so, a SWOT analysis was conducted.
Results
The present study demonstrated that SARS-CoV-2 significantly reduced ejaculate volume, sperm count, concentration, viability, normal morphology, and total and progressive motility. Furthermore, SARS-CoV-2 led to a reduction in circulating testosterone level, but a rise in oestrogen, prolactin, and luteinizing hormone levels. These findings were associated with a decline in testosterone/luteinizing hormone ratio.
Conclusions
The current study provides compelling evidence that SARS-CoV-2 may lower male fertility by reducing semen quality through a hormone-dependent mechanism; reduction in testosterone level and increase in oestrogen and prolactin levels.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Medical Faculty, Department of Cardiovascular Surgery and Research Group for Experimental Surgery, Cardiovascular Regenerative Medicine and Tissue Engineering 3D Lab, Heinrich Heine University, Düsseldorf, Germany.
- Reproductive Biology and Toxicology Research Laboratory, Oasis of Grace Hospital, Osogbo, Nigeria.
- Department of Physiology, Ladoke Akintola University of Technology, Ogbomosho, Oyo State, Nigeria.
- Department of Agronomy, Breeding and Genetic Unit, Osun State University, Osun State, Nigeria.
ORCID-Profile: R E Akhigbe
Zitieren
APA
V J, A., P J, A., T M, A., & Akhigbe, R. E. (2024). SARS-CoV-2 impairs male fertility by targeting semen quality and testosterone level: A systematic review and meta-analysis. PLOS ONE, 19(9), e0307396. https://doi.org/10.1371/journal.pone.0307396
Vancouver
V J A, P J A, T M A, Akhigbe RE. SARS-CoV-2 impairs male fertility by targeting semen quality and testosterone level: A systematic review and meta-analysis. PLOS ONE. 2024;19(9):e0307396. doi:10.1371/journal.pone.0307396
BibTeX
@article{VJ2024,
author = {V J, Ashonibare and P J, Ashonibare and T M, Akhigbe and Akhigbe, R E},
title = {SARS-CoV-2 impairs male fertility by targeting semen quality and testosterone level: A systematic review and meta-analysis},
journal = {PLOS ONE},
year = {2024},
volume = {19},
number = {9},
pages = {e0307396},
doi = {10.1371/journal.pone.0307396}
}
EUVIMED